Literature DB >> 25664031

Reduced mir-29b-3p expression up-regulate CDK6 and contributes to IgA nephropathy.

Li-Na Xing1, Hao Wang1, Pei-Hao Yin1, Yu-Jun Liu1, Yang-Feng Chi1, Yun-Man Wang1, Wen Peng1.   

Abstract

IgA nephropathy (IgAN) is the most common glomerulonephritis and the etiology of which is complex and multiple, and the pathological damage of IgAN is diversified. MicroRNA is a kind of gene expression suppressor and recently, researchers have found that microRNAs may play an important role in the pathogenesis of IgAN. Herein, we found that miR-29b-3p not miR-29a or miR-29c was significantly down regulated in IgAN patients' renal tissues. Predicted by bioinformatics tools and confirmed by dual luciferase assay and western blot, we found that the expression of CDK6 was repressed by miR-29b-3p directly. Subsequently, we found that miR-29b-3p down-regulation caused CDK6 overexpression can promote NF-κB signal by phosphorylating p65 which may enhance inflammation during IgAN pathogenesis.

Entities:  

Keywords:  CDK6; IgA nephropathy; MicroRNA; p65; phosphorylation

Year:  2014        PMID: 25664031      PMCID: PMC4307478     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  14 in total

1.  Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.

Authors:  Hyun Soon Lee; Myung Suk Lee; Sa Min Lee; Sang Yun Lee; Eun Sun Lee; Eun Young Lee; So Yeon Park; Jin Suk Han; Sungkwon Kim; Jung Sang Lee
Journal:  Nephrol Dial Transplant       Date:  2004-12-23       Impact factor: 5.992

2.  Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy.

Authors:  Grazia Serino; Fabio Sallustio; Sharon N Cox; Francesco Pesce; Francesco P Schena
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

3.  Toll-like receptor-4 (TLR4) down-regulates microRNA-107, increasing macrophage adhesion via cyclin-dependent kinase 6.

Authors:  Elizabeth J Hennessy; Frederick J Sheedy; David Santamaria; Mariano Barbacid; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

4.  Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.

Authors:  J Xu; Y Li; F Wang; X Wang; B Cheng; F Ye; X Xie; C Zhou; W Lu
Journal:  Oncogene       Date:  2012-04-02       Impact factor: 9.867

Review 5.  Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors.

Authors:  G D'Amico
Journal:  Am J Kidney Dis       Date:  2000-08       Impact factor: 8.860

Review 6.  MicroRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Hoell; Pavel Morozov; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Microarray analysis of micro-ribonucleic acid expression in primary immunoglobulin A nephropathy.

Authors:  Yong Dai; Weiguo Sui; Huijuan Lan; Qiang Yan; He Huang; Yuanshuai Huang
Journal:  Saudi Med J       Date:  2008-10       Impact factor: 1.484

8.  Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.

Authors:  Gang Wang; Bonnie Ching-Ha Kwan; Fernand Mac-Moune Lai; Kai-Ming Chow; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Dis Markers       Date:  2010       Impact factor: 3.434

9.  MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders.

Authors:  Olivier C Maes; Howard M Chertkow; Eugenia Wang; Hyman M Schipper
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

10.  Cyclin-dependent kinase 6 phosphorylates NF-κB P65 at serine 536 and contributes to the regulation of inflammatory gene expression.

Authors:  Holger Buss; Katja Handschick; Nadine Jurrmann; Pirita Pekkonen; Knut Beuerlein; Helmut Müller; Robin Wait; Jeremy Saklatvala; Päivi M Ojala; M Lienhard Schmitz; Michael Naumann; Michael Kracht
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more
  8 in total

1.  MicroRNA-29b-3p reduces intestinal ischaemia/reperfusion injury via targeting of TNF receptor-associated factor 3.

Authors:  Yan Dai; Zhang Mao; Xu Han; Youwei Xu; Lina Xu; Lianhong Yin; Yan Qi; Jinyong Peng
Journal:  Br J Pharmacol       Date:  2019-07-17       Impact factor: 8.739

Review 2.  Markers for the progression of IgA nephropathy.

Authors:  Dita Maixnerova; Colin Reily; Qi Bian; Michaela Neprasova; Jan Novak; Vladimir Tesar
Journal:  J Nephrol       Date:  2016-05-03       Impact factor: 3.902

3.  MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy?

Authors:  Haresh Selvaskandan; Izabella Pawluczyk; Jonathan Barratt
Journal:  Clin Kidney J       Date:  2017-09-23

Review 4.  The Role of MicroRNAs in Selected Forms of Glomerulonephritis.

Authors:  Magdalena Nalewajska; Klaudia Gurazda; Ewa Styczyńska-Kowalska; Małgorzata Marchelek-Myśliwiec; Andrzej Pawlik; Violetta Dziedziejko
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

5.  Decreased expression of miR-29 family associated with autoimmune myasthenia gravis.

Authors:  Mélanie A Cron; Cloé A Payet; Odessa-Maud Fayet; Solène Maillard; Frédérique Truffault; Elie Fadel; Julien Guihaire; Sonia Berrih-Aknin; Adrian Liston; Rozen Le Panse
Journal:  J Neuroinflammation       Date:  2020-10-08       Impact factor: 8.322

6.  Bioinformatics analysis of mRNA profiles and identification of microRNA-mRNA network in CD4+ T cells in seasonal allergic rhinitis.

Authors:  Peng Jin; Hongping Zhang; Xilin Zhu; Kaiyue Sun; Tao Jiang; Li Shi; Lili Zhi; Hailing Zhang
Journal:  J Int Med Res       Date:  2022-08       Impact factor: 1.573

Review 7.  The Non-Coding RNA Landscape in IgA Nephropathy-Where Are We in 2021?

Authors:  Izabella Z A Pawluczyk; Haresh Selvaskandan; Jonathan Barratt
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

8.  MiR-29b-3p promotes particulate matter-induced inflammatory responses by regulating the C1QTNF6/AMPK pathway.

Authors:  Jian Wang; Mengchan Zhu; Ling Ye; Cuicui Chen; Jun She; Yuanlin Song
Journal:  Aging (Albany NY)       Date:  2020-01-18       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.